Search

How Can We Help You?

Video

Quick Info:

Find a Doctor Specialties (800) 213-3284

Go To Home PageBack

Breast Cancer Trials

Select Clinical Trial

Protocol Number: NSABP B-61, GO42784

Protocol Title: A Phase III, Randomized, Open-Label, Multicenter Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared with Physician's Choice of Adjuvant Endocrine Monotherapy in Patients with Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer. 

Eligibility: Men or women ages 18 and older, diagnosed with ER positive, HER2 negative breast tumor, stage 1-3. Participants who have received (neo)adjuvant chemotherapy and/or had surgery and had no prior endocrine therapy

Contact Information: (910) 715-2200

____________________________________________________________________________________________

Protocol Number: URCC16070, NCT 03367572

Protocol Title: Treatment of Refractory Nausea

Eligibility: Men or women ages 18 and older, receiving chemotherapy for breast cancer. 

Contact Information: (910) 715-2200

 

Specialties
Clara McLean House
Make a Donation
News & Events